ADMA Biologics Inc ADMA:NASDAQ

Last Price$2.41Cboe Real-Time Last Sale as of 10:18AM ET 8/17/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.01(0.42%)
Bid (Size)$2.40 (800)
Ask (Size)$2.41 (654)
Day Low / High$2.36 - 2.44
Volume326.6 K
 

View Biotechnology IndustryPeer Comparison as of 08/17/2022

 

ADMA Biologics Inc ( NASDAQ )

Price: $2.41
Change: +0.01 (0.42%)
Volume: 326.6 K
10:18AM ET 8/17/2022
 
 

MeiraGTx Holdings PLC ( NASDAQ )

Price: $10.05
Change: -0.47 (4.47%)
Volume: 8.9 K
10:21AM ET 8/17/2022
 
 

MiMedx Group Inc ( NASDAQ )

Price: $4.21
Change: -0.01 (0.24%)
Volume: 42.0 K
10:22AM ET 8/17/2022
 
 

Precigen Inc ( NASDAQ )

Price: $2.39
Change: -0.02 (0.83%)
Volume: 70.8 K
10:22AM ET 8/17/2022
 
 

Scholar Rock Holding Corp ( NASDAQ )

Price: $9.74
Change: +0.02 (0.21%)
Volume: 33.0 K
10:17AM ET 8/17/2022
 

Read more news Recent News

Update: ADMA Biologics Q2 Loss Narrows as Revenue Rises -- Shares Jump Thursday
12:44PM ET 8/11/2022 MT Newswires

(Updates with share price movement in headline and first paragraph.) ADMA Biologics (ADMA) shares rose by more than 10% in Thursday afternoon trading, a...

ADMA Biologics Loss Narrows After Revenue Almost Doubles in Q2; Shares Rise After Hours
4:54PM ET 8/10/2022 MT Newswires

ADMA Biologics (ADMA) reported a Q2 diluted loss late Wednesday of $0.07, narrowing from a $0.15 loss a year earlier. Analysts polled by Capital IQ...

-- Earnings Flash (ADMA) ADMA BIOLOGICS Reports Q2 Revenue $33.9M, vs. Street Est of $31.8M
4:08PM ET 8/10/2022 MT Newswires

...

-- Earnings Flash (ADMA) ADMA BIOLOGICS Reports Q2 Loss $-0.07, vs. Street Est of $-0.08
4:08PM ET 8/10/2022 MT Newswires

...

Company Profile

Business DescriptionADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ. View company web site for more details
Address465 State Route 17 South
Ramsey, New Jersey 07446
Phone+1.201.478.5552
Number of Employees318
Recent SEC Filing08/10/20228-K
President, Chief Executive Officer & DirectorAdam S. Grossman
Operations DirectorAtkinson Vernon
Chief Financial Officer & Executive Vice PresidentBrian Lenz
Vice President-Compliance & Clinical OperationsKaitlin Kestenberg

Company Highlights

Price Open$2.35
Previous Close$2.40
52 Week Range$1.01 - 2.48
Market Capitalization$473.2 M
Shares Outstanding196.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/09/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.40
Beta vs. S&P 500N/A
Revenue$17.0 M
Net Profit Margin-66.44%
Return on Equity-60.28%

Analyst Ratings as of 07/22/2022

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset